Museum specimens offer new lens on pollution history
Peer-Reviewed Publication
Updates every hour. Last Updated: 20-Jun-2025 06:10 ET (20-Jun-2025 10:10 GMT/UTC)
A novel screening approach developed by physicians at the Lewis Katz School of Medicine at Temple University shows significant promise for improving the detection of pulmonary arterial hypertension (PAH)—a life-threatening form of heart failure related to high blood pressure in the lung circulation that is often overlooked due to vague symptoms such as fatigue and shortness of breath.
The new research, published online April 5 in the American Heart Journal, shows that the virtual echocardiography screening tool (VEST), when incorporated into the electronic medical record (EMR) system, can generate accurate PAH risk scores—without the need for time-consuming manual calculations. The approach is the first of its kind in the field of pulmonary vascular medicine.